Cervical Cancer Vaccine In addition to the Pap smear, one of the many other preventive strategies known is through a vaccine. Data from the latest research, conferences IPV (International Papilloma Virus) to-24 in Beijing showed that cervical cancer vaccine already exists and circulating in Indonesia is currently effective, and can provide protection for women up to age 45 years. This vaccine prevents 91% of persistent infections, mild abnormalities, pre-cancerous lesions, and warts in the genital area caused by certain HPV virus compared with the placebo group. Prevention efforts in the form of vaccination and cervical cancer early detection is important because it can help reduce the prevalence rate of cervical cancer. According to data from the International Agency for Research on Cancer, HPV has been shown to be associated with more than 95% of cases of cervical cancer. The virus is spread through sexual contact and skin to skin contact in the genital area, so that every sexually active woman is at risk. In addition to cervical cancer, HPV virus also causes other problems such as: 1. Cervical dysplasia (abnormal cervical cell growth) 2. Genital warts (warts on the genitals) 3. Vulvar cancer, and so on Cervical cancer vaccine proves effective against pre-cancerous lesions associated with HPV type to-16 and 18 (two types of main causes of cervical cancer 70% of cases).